Jane Manalo, MD | Authors

Novel Combinations With Oxaliplatin

December 01, 2000

Oxaliplatin (Eloxatin) is a novel antineoplastic platinum derivative that may exert its cytotoxic effects by blocking DNA replication/transcription, thus resulting in cell death in proliferating cells, as well as apoptosis.